UBS raises Repligen price target to $225 from $195
UBS raised its Repligen price target to $225.00 per share from $195.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.